• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将经济评估作为卫生技术评估过程的一部分进行反复使用。

The iterative use of economic evaluation as part of the process of health technology assessment.

作者信息

Sculpher M, Drummond M, Buxton M

机构信息

Health Economics Research Group, Brunel University, UK.

出版信息

J Health Serv Res Policy. 1997 Jan;2(1):26-30. doi: 10.1177/135581969700200107.

DOI:10.1177/135581969700200107
PMID:10180650
Abstract

The economic evaluation of health care technologies has a key role within the new National Health Service health technology assessment process. There has, however, been little discussion of the best way of combining economic and clinical research. Economic evaluation should be iterative, generating progressively firmer estimates of cost-effectiveness and helping to maximise the efficiency of health care R&D. Here, four stages of economic analysis are suggested, starting with stage I when the basic clinical science is complete, and finishing with stage IV analysis to generalise the results of earlier studies to routine clinical practice.

摘要

卫生保健技术的经济评估在新的国民医疗服务体系卫生技术评估过程中起着关键作用。然而,关于将经济研究与临床研究相结合的最佳方式,却鲜有讨论。经济评估应该是迭代式的,逐步得出更可靠的成本效益估计,并有助于最大限度地提高卫生保健研发的效率。本文提出了经济分析的四个阶段,从基础临床科学完成后的第一阶段开始,到将早期研究结果推广至常规临床实践的第四阶段分析结束。

相似文献

1
The iterative use of economic evaluation as part of the process of health technology assessment.将经济评估作为卫生技术评估过程的一部分进行反复使用。
J Health Serv Res Policy. 1997 Jan;2(1):26-30. doi: 10.1177/135581969700200107.
2
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.推理的无关性:一种用于医疗技术随机评估的决策方法。
J Health Econ. 1999 Jun;18(3):341-64. doi: 10.1016/s0167-6296(98)00039-3.
3
Handling uncertainty in economic evaluations of healthcare interventions.应对医疗保健干预措施经济评估中的不确定性。
BMJ. 1999 Sep 4;319(7210):635-8. doi: 10.1136/bmj.319.7210.635.
4
Cost collection and analysis for health economic evaluation.卫生经济评价的成本收集与分析。
Otolaryngol Head Neck Surg. 2013 Aug;149(2):192-9. doi: 10.1177/0194599813487850. Epub 2013 May 2.
5
How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.成本效益分析应如何用于卫生技术覆盖决策?来自英国国家卫生与临床优化研究所方法的证据。
J Health Serv Res Policy. 2007 Apr;12(2):73-9. doi: 10.1258/135581907780279521.
6
Use of evidence in economic decision models: practical issues and methodological challenges.经济决策模型中证据的使用:实际问题与方法挑战
Health Econ. 2007 Dec;16(12):1277-86. doi: 10.1002/hec.1297.
7
Economic appraisal in the British National Health Service: implications of recent developments.英国国民医疗服务体系中的经济评估:近期发展的影响
Soc Sci Med. 1994 Jun;38(12):1615-23. doi: 10.1016/0277-9536(94)90062-0.
8
Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.健康技术的综合分布成本效益分析。
Value Health. 2019 May;22(5):518-526. doi: 10.1016/j.jval.2019.03.006.
9
Problems of using modelling in the economic evaluation of health care.医疗保健经济评估中使用建模的问题。
Health Econ. 1996 Jan-Feb;5(1):1-11. doi: 10.1002/(SICI)1099-1050(199601)5:1<1::AID-HEC183>3.0.CO;2-K.
10
COMPARISON OF METHODS FOR ESTIMATING CONTEMPORARY COSTS: AN APPLICATION TO LIVER TRANSPLANTATION IN THE UNITED KINGDOM.当代成本估算方法的比较:以英国肝移植为例。
Int J Technol Assess Health Care. 2017 Jan;33(6):620-628. doi: 10.1017/S026646231700071X. Epub 2017 Sep 22.

引用本文的文献

1
Palin Stuttering Therapy for School aged Children and usual treatment: A randomised controlled trial feasibility study.针对学龄儿童的佩林口吃疗法与常规治疗:一项随机对照试验可行性研究。
J Fluency Disord. 2025 Jun;84:106114. doi: 10.1016/j.jfludis.2025.106114. Epub 2025 Mar 1.
2
Preparing early economic evaluations for the development and management of health service interventions.为卫生服务干预措施的制定和管理编写早期经济评价。
Int J Technol Assess Health Care. 2024 Oct 18;40(1):e47. doi: 10.1017/S0266462324000539.
3
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study.
评估抗逆转录病毒疗法随时间推移的成本效益:一项队列研究和成本效益研究
Pharmacoecon Open. 2024 Nov;8(6):847-856. doi: 10.1007/s41669-024-00513-7. Epub 2024 Jul 30.
4
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening.一种决策分析模型验证的结构化流程:在风险分层国家乳腺癌筛查成本效益模型中的应用。
Appl Health Econ Health Policy. 2024 Jul;22(4):527-542. doi: 10.1007/s40258-024-00887-z. Epub 2024 May 16.
5
Explorative cost-effectiveness analysis of colorectal cancer recurrence detection with next-generation sequencing liquid biopsy in Spain, France, and Germany.西班牙、法国和德国采用下一代测序液体活检检测结直肠癌复发的探索性成本效益分析。
Therap Adv Gastroenterol. 2024 May 10;17:17562848241248246. doi: 10.1177/17562848241248246. eCollection 2024.
6
Economic evaluations in medical technological innovations a mapping review of methodologies.医学技术创新中的经济评估:方法学的映射综述
Cost Eff Resour Alloc. 2024 Mar 19;22(1):23. doi: 10.1186/s12962-024-00529-0.
7
The economic burden of difficult intravenous access in the emergency department from a United States' provider perspective.从美国医疗机构的角度看急诊科静脉穿刺困难的经济负担。
J Res Nurs. 2024 Feb;29(1):6-18. doi: 10.1177/17449871231213025. Epub 2024 Jan 16.
8
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework.健康与医学中基于模型的决策的迭代方法指南:迭代决策框架。
Pharmacoeconomics. 2024 Apr;42(4):363-371. doi: 10.1007/s40273-023-01341-z. Epub 2023 Dec 29.
9
Decision-analytic modeling for early health technology assessment of medical devices - a scoping review.医疗器械早期卫生技术评估的决策分析模型——范围综述。
Ger Med Sci. 2022 Dec 21;20:Doc11. doi: 10.3205/000313. eCollection 2022.
10
Using early health economic modeling to inform medical innovation development: a soft robotic sock in poststroke patients in Singapore.利用早期健康经济模型为医疗创新研发提供信息:新加坡脑卒中患者的一款软机器人袜子。
Int J Technol Assess Health Care. 2023 Jan 11;39(1):e4. doi: 10.1017/S026646232200335X.